TILT Biotherapeutics

TILT Biotherapeutics is a biotech company in Helsinki, Finland, founded in 2013. It has raised $38.9M across 3 rounds, most recently a $25.6M Series B in May 2025.

Headquarters
Helsinki, Uusimaa
Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$38.9M
Last Round
$25.6M Series BMay 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

TILT Biotherapeutics is the world's leading company developing oncolytic immunotherapies to enable T-cell therapies for solid tumors. The company has carried its lead adenoviral immunotherapy candidate, TILT-123, through Phase I trials with patients from around the world. Its scientific approach, led by Dr. Hemminki's research team, used patient observations and proof-of-concept data to confirm the pivotal role of immunity in combating cancer with oncolytic virus therapies.

Summary

It lists 11–50 employees. It has raised $38.9M in total across 3 rounds, most recently a $25.6M Series B round in May 2025. Investors include Lifeline Ventures, European Innovation Council Fund and Tesi.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BMay 2025
$25.6M

Sign up to see all 3 events

Funding: Grant through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TILT Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tilt-biotherapeutics"><img src="https://indexed.vc/api/badge/company/tilt-biotherapeutics" alt="TILT Biotherapeutics on Indexed.vc" width="260" height="76" /></a>